| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR | 700,000 | 134,141,000 | 15.97% | Call | |
| 2 | ISHARES TR | 762,000 | 94,137,000 | 11.21% | Call | |
| 3 | ISHARES TR | 600,000 | 65,520,000 | 7.80% | Put | |
| 4 | PATTERSON COS INC | 1,225,000 | 52,981,000 | 6.31% | ||
| 5 | ENDOLOGIX INC | 4,050,000 | 49,653,000 | 5.91% | ||
| 6 | MEDTRONIC PLC | 700,000 | 46,858,000 | 5.58% | ||
| 7 | QUEST DIAGNOSTICS INC | 700,000 | 43,029,000 | 5.12% | ||
| 8 | GREATBATCH INC | 700,000 | 39,494,000 | 4.70% | ||
| 9 | BECTON DICKINSON & CO | 275,000 | 36,482,000 | 4.34% | ||
| 10 | NXSTAGE MED INC COM | 2,000,000 | 31,540,000 | 3.75% | ||
| 11 | ALLSCRIPTS HEALTHCARE | 2,150,000 | 26,660,000 | 3.17% | ||
| 12 | IMPRIVATA INC | 1,425,000 | 25,322,000 | 3.01% | ||
| 13 | ALKERMES PLC SHS | 365,000 | 21,415,000 | 2.55% | ||
| 14 | MERCK & CO INC | 400,000 | 19,756,000 | 2.35% | Call | |
| 15 | ATRICURE INC | 825,000 | 18,076,000 | 2.15% | ||
| 16 | LUMINEX CORP DEL COM | 950,000 | 16,065,000 | 1.91% | ||
| 17 | BIO RAD LABS INC CL A | 110,000 | 14,774,000 | 1.76% | ||
| 18 | PERRIGO CO PLC | 80,000 | 12,582,000 | 1.50% | Call | |
| 19 | CORIUM INTERNATIONAL INC | 1,325,000 | 12,389,000 | 1.47% | ||
| 20 | TEVA PHARMACEUTICAL INDS LTD | 200,000 | 11,292,000 | 1.34% | Call | |
| 21 | RTI SURGICAL HOLDINGS INC COM | 1,950,000 | 11,076,000 | 1.32% | ||
| 22 | AMARIN CORP PLC | 5,700,000 | 11,001,000 | 1.31% | ||
| 23 | AMGEN INC | 75,000 | 10,374,000 | 1.23% | ||
| 24 | SPECTRANETICS CORP | 785,000 | 9,255,000 | 1.10% | ||
| 25 | PERRIGO CO PLC | 50,000 | 7,864,000 | 0.94% | ||
| 26 | Oxford Immunotec Global PLC | 375,000 | 5,063,000 | 0.60% | ||
| 27 | CERUS CORP | 900,000 | 4,086,000 | 0.49% | ||
| 28 | LANTHEUS HLDGS INC COM | 615,000 | 2,645,000 | 0.31% | ||
| 29 | STREAMLINE HEALTH SOLUTIONS COM | 1,138,000 | 2,606,000 | 0.31% | ||
| 30 | HERON THERAPEUTICS INC | 75,000 | 1,830,000 | 0.22% | ||
| 31 | NUVASIVE INC COM | 25,000 | 1,206,000 | 0.14% | ||
| 32 | GLOBUS MED INC | 45,000 | 930,000 | 0.11% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001095449-15-000149, filed 2015.11.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.